IFF
69
13
KR
59
10
URI
63
3
GWW
51
-2
PFE
37
-3
STX
59
-5
ADP
68
2
AIV
62
-2
C
48
-2
CB
57
3
ECL
84
2
MU
56
-3
UHS
60
-3
UNM
70
2
HD
35
-11
NVDA
60
-3
JPM
71
2
NAVI
36
-2
CVX
25
2
SYF
83
2
IFF
69
13
KR
59
10
URI
63
3
GWW
51
-2
PFE
37
-3
STX
59
-5
ADP
68
2
AIV
62
-2
C
48
-2
CB
57
3
ECL
84
2
MU
56
-3
UHS
60
-3
UNM
70
2
HD
35
-11
NVDA
60
-3
JPM
71
2
NAVI
36
-2
CVX
25
2
SYF
83
2
Financhill
Back

Regulus Therapeutics Stock Predictions

Sell
35

RGLS
Regulus Therapeutics

Last Price:
1.99
Seasonality Move:
-26.42%

7 Day Trial

ALL ACCESS PASS

$ 7

Regulus Therapeutics Stock Forecast

  • Is Regulus Therapeutics Stock Undervalued?
    The current Regulus Therapeutics [RGLS] share price is $2.00. The Score for RGLS is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • RGLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Regulus Therapeutics Stock Go Up Next Year?

Data Unavailable

Regulus Therapeutics Stock Rating

Data Unavailable

Regulus Therapeutics Stock Price History

Is RGLS stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGLS is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
regulusrx.com

52-Week Data

52-Week High:
3.79
52-Week Low:
1.08

Prediction Charts

Market Cap:
130.93M
Price in USD:
2.00
Volume:
263.32K
Beta:
1.73

Technical Analysis

SMA50:
2.41
SMA100:
1.89
SMA200:
1.64
52-Wk Change:
22.7%

Stock Predictions

  • Is Regulus Therapeutics stock public?
    Yes, Regulus Therapeutics is a publicly traded company.
  • What is the Regulus Therapeutics stock quote today?
    The Regulus Therapeutics stock price is 2.00 USD today.
  • How to buy Regulus Therapeutics stock online?
    You can buy Regulus Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-30 2.51 2.30 2.59 2.30
May-1 2.30 2.50 2.67 2.21
May-2 2.53 2.69 2.90 2.49
May-3 2.83 2.65 2.83 2.64
May-6 2.71 2.43 2.79 2.40
May-7 2.43 2.23 2.49 2.18
May-8 2.20 2.27 2.32 2.16
May-9 2.26 2.23 2.36 2.20
May-10 2.13 2.21 2.34 2.13
May-13 2.21 2.09 2.28 2.03
May-14 2.10 2.08 2.17 2.01
May-15 2.09 2.02 2.13 1.94
May-16 2.01 2.00 2.11 1.95
May-17 2.05 2.00 2.10 1.95

Regulus Therapeutics Earnings

Data Unavailable

Regulus Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.05 per share, an increase this year of $0.95 per share, and a decrease next year of $0.12 per share.

* Regulus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.